oleoyl-estrone (oleoyl estrone)

06/01/2000 - "Treatment with oleoyl-estrone resulted in a marked decrease in body weight in both strains, compared with the unchecked growth of controls. "
01/01/2004 - "Oleoyl-estrone and pair-fed groups expressed similar variations in body composition and significant body weight losses due to reduction in food intake. "
10/18/2003 - "Oleoyl-estrone decreased the body weight (38.5 kg in 27 months, final BMI: 40.5). "
08/01/2003 - "Oleoyl-estrone induced the loss of body weight (mainly body fat) in all groups. "
11/01/2000 - "To test whether oleoyl-estrone plus a hyperlipidic diet affects body weight in Zucker fa/fa rats, 13-week-old male Zucker obese (fa/fa) rats initially weighing 440-470 g were used. "

10/18/2003 - "Our objective was to determine whether oral oleoyl-estrone was effective in the treatment of morbid obesity in a voluntary patient. "
10/18/2003 - "[Weight loss in a patient with morbid obesity under treatment with oleoyl-estrone]."

03/01/2009 - "Overweight male rats received oral oleoyl-estrone (OE) for 10 days, and were compared with controls. "
07/01/2006 - "Combined effects of oral oleoyl-estrone and limited food intake on body composition of young overweight male rats."
04/01/2010 - "Site-specific modulation of white adipose tissue lipid metabolism by oleoyl-estrone and/or rosiglitazone in overweight rats."
01/01/2010 - "Oleoyl-estrone increases adrenal corticosteroid synthesis gene expression in overweight male rats."
08/01/2009 - "Site-related white adipose tissue lipid-handling response to oleoyl-estrone treatment in overweight male rats."

05/01/2005 - "Oral treatment with oleoyl-estrone induces the loss of body fat and improvement of insulin resistance. "
04/25/2005 - "All oleoyl-estrone-treated rats showed increased insulin sensitivity. "
04/01/2010 - "In spite of their shared decrease of insulin resistance, oleoyl-estrone [OE], and rosiglitazone show diverging effects on body fat mass and distribution. "
06/01/2007 - "Oleoyl-estrone (OE) decreases appetite, maintains energy expediture, induces lipolysis (sparing protein), and decreases cholesterolemia and insulin resistance. "
04/01/2011 - "Oleoyl-estrone (OE) is a powerful anti-obesity compound that decreases food intake, decreases insulin resistance and circulating cholesterol. "

08/01/2006 - "To determine whether or not the long-term intermittent treatment with oleoyl-estrone (OE) in rats induces a cumulative weight loss, adult male rats were treated with OE over three alternating 10-day periods, with a 30-day "recovery" period occurring between each period. "
08/01/2006 - "Weight loss with long-term intermittent treatment with oral oleoyl-estrone in lean Zucker male rats."
10/18/2003 - "[Weight loss in a patient with morbid obesity under treatment with oleoyl-estrone]."
04/09/2014 - "Oleoyl chalcones 4d, 4e and particularly 6a as an isosteric isomer of oleoyl estrone, were as active as Orlistat on weight loss and related metabolic parameters using male SD rats in vivo. "
12/01/1997 - "Oleoyl-estrone given i.v.--incorporated in liposomes to mimic lipoprotein delivery--(Merlin-2) to normal weight rats, induces a dose-dependent weight loss. "